Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
| Distributed by / for | Carolina Infusion, LLC |
| Full product label | SERMORELIN ACETATE 1 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland |
| Recalling firm | Carolina Infusion, LLC |
| Distribution | Nationwide within the U.S |
| Quantity | 15 mls - in patient specific syringe doses |
| Recall initiated | 2026-09-10 |
| Report date | 2026-10-14 |
| Recall completed | — |
| Recall number | D-0020-2027 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Ridgeland SC United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗